Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 39 results.
User Information
Export Records
  1. 1.   The Design of a Participatory Peptide Nucleic Acid Duplex Crosslinker to Enhance the Stiffness of Self-Assembled Peptide Gels
  2. Sarkar,Srijani; Anderson,Caleb; Schneider,Joel
  3. Angewandte Chemie (International ed. in English). 2023, Dec 06; e202313507.
  1. 2.   From structure to application: Progress and opportunities in peptide materials development
  2. Lopez Silva,Tania; Schneider,Joel
  3. Current Opinion in Chemical Biology. 2021, Oct; 64: 131-144.
  1. 3.   A New Mixed All-Atom/Coarse-Grained Model: Application to Melittin Aggregation in Aqueous Solution
  2. Shelley, Mee Y.; SeIvan, Myvizhi Esai; Zhao, Jun; Babin, Volodymyr; Liao, Chenyi; Li, Jianing; Shelley, John C.
  3. JOURNAL OF CHEMICAL THEORY AND COMPUTATION. 2017, Aug; 13(8): 3881-3897.
  1. 4.   A Protocol for the Design of Protein and Peptide Nanostructure Self-Assemblies Exploiting Synthetic Amino Acids.
  2. Haspel, Nurit; Zheng, Jie; Aleman, Carlos; Zanuy, David; Nussinov, Ruth
  3. Methods in molecular biology (Clifton, N.J.). 2017 1529: 323-352.
  1. 5.   A Single Polymorphism in HIV-1 Subtype C SP1 Is Sufficient To Confer Natural Resistance to the Maturation Inhibitor Bevirimat
  2. Lu, W. X.; Salzwedel, K.; Wang, D.; Chakravarty, S.; Freed, E. O.; Wild, C. T.; Li, F.
  3. Antimicrobial Agents and Chemotherapy. 2011, Jul; 55(7): 3324-3329.
  1. 6.   Viral envelope protein folding and membrane hemifusion are enhanced by the conserved loop region of HIV-1 gp41
  2. Ashkenazi, A.; Viard, M.; Wexler-Cohen, Y.; Blumenthal, R.; Shai, Y.
  3. Faseb Journal. 2011, Jul; 25(7): 2156-2166.
  1. 7.   Virus-cell and cell-cell fusion mediated by the HIV-1 envelope glycoprotein is inhibited by short gp41 N-terminal membrane-anchored peptides lacking the critical pocket domain
  2. Wexler-Cohen, Y.; Ashkenazi, A.; Viard, M.; Blumenthal, R.; Shai, Y.
  3. Faseb Journal. 2010, Nov; 24(11): 4196-4202.
  1. 8.   The G-protein-coupled formylpeptide receptor FPR confers a more invasive phenotype on human glioblastoma cells
  2. Huang, J.; Chen, K.; Chen, J.; Gong, W.; Dunlop, N. M.; Howard, O. M. Z.; Gao, Y.; Bian, X. W.; Wang, J. M.
  3. British Journal of Cancer. 2010, Mar 16; 102(6): 1052-1060.
  1. 9.   APOBEC3G expression is dysregulated in primary HIV-1 infection and polymorphic variants influence CD4+ T-cell counts and plasma viral load
  2. Reddy, K.; Winkler, C. A.; Werner, L.; Mlisana, K.; Karim, S. S. A.; Ndung'u, T.; Team, C. A. I. S.
  3. Aids. 2010, Jan; 24(2): 195-204.
  1. 10.   Functional characterization of filamin A interacting protein 1-like, a novel candidate for antivascular cancer therapy
  2. Kwon, M.; Hanna, E.; Lorang, D.; He, M.; Quick, J. S.; Adem, A.; Stevenson, C.; Chung, J. Y.; Hewitt, S. M.; Zudaire, E.; Esposito, D.; Cuttitta, F.; Libutti, S. K.
  3. Cancer Research. 2008 68(18): 7332-7341.
  1. 11.   Synthesis of a homologous series of side-chain-extended orthogonally protected aminooxy-containing amino acids
  2. Liu, F.; Thomas, J.; Burke, T. R.
  3. Synthesis-Stuttgart. 2008 (15): 2432-2438.
  1. 12.   ELR+-CXC chemokines and their receptors in early metanephric development
  2. Levashova, Z. B.; Sharma, N.; Timofeeva, O. A.; Dome, J. S.; Perantoni, A. O.
  3. Journal of the American Society of Nephrology. 2007, Aug; 18(8): 2359-2370.
  1. 13.   Stereochemical restraints revisited: how accurate are refinement targets and how much should protein structures be allowed to deviate from them?
  2. Jaskolski, M.; Gilski, M.; Dauter, Z.; Wlodawer, A.
  3. Acta Crystallographica Section D-Biological Crystallography. 2007, May; 63: 611-620.
  1. 14.   Structure by design: from single proteins and their building blocks to nanostructures
  2. Tsai, C. J.; Zheng, J.; Aleman, C.; Nussinov, R.
  3. Trends in Biotechnology. 2006, Oct; 24(10): 449-454.
  1. 15.   Mass spectrometric analysis of the HIV-1 integrase-pyridoxal 5 '-phosphate complex reveals a new binding site for a nucleotide inhibitor
  2. Williams, K. L.; Zhang, Y. J.; Shkriabai, N.; Karki, R. G.; Nicklaus, M. C.; Kotrikadze, N.; Hess, S.; Le Grice, S. F. J.; Craigie, R.; Pathak, V. K.; Kvaratskhelia, M.
  3. Journal of Biological Chemistry. 2005, MAR 4; 280(9): 7949-7955.
  1. 16.   Synthesis of trishomocubane amino acid derivatives
  2. Govender, T.; Hariprakasha, H. K.; Kruger, H. G.; Raasch, T.
  3. South African Journal of Chemistry-Suid-Afrikaanse Tydskrif Vir Chemie. 2005 58: 37-40.
  1. 17.   Solution structure of the cyclotide palicourein: Implications for the development of a pharmaceutical framework
  2. Barry, D. G.; Daly, N. L.; Bokesch, H. R.; Gustafson, K. R.; Craik, D. J.
  3. Structure. 2004 12(1): 85-94.
  1. 18.   Reversion of CTL escape-variant immunodeficiency viruses in vivo
  2. Friedrich, T. C.; Dodds, E. J.; Yant, L. J.; Vojnov, L.; Rudersdorf, R.; Cullen, C.; Evans, D. T.; Desrosiers, R. C.; Mothe, B. R.; Sidney, J.; Sette, A.; Kunstman, K.; Wolinsky, S.; Piatak, M.; Lifson, J.; Hughes, A. L.; Wilson, N.; O'Connor, D. H.; Watkins, D. I.
  3. Nature Medicine. 2004 10(3): 275-281.
  1. 19.   Cyclonellin, a new cyclic octapeptide from the marine sponge Axinella carteri
  2. Milanowski, D. J.; Rashid, M. A.; Gustafson, K. R.; O'Keefe, B. R.; Nawrocki, J. P.; Pannell, L. K.; Boyd, M. R.
  3. Journal of Natural Products. 2004 67(3): 441-444.
  1. 20.   Synthesis of alpha,alpha-disubstituted 4-phosphonophenylalanine analogues as conformationally-constrained phosphotyrosyl mimetics
  2. Oishi, S.; Kang, S. U.; Liu, H. P.; Zhang, M. C.; Yang, D. J.; Deschamps, J. R.; Burke, T. R.
  3. Tetrahedron. 2004 60(13): 2971-2977.
  1. 21.   Development of L-3-aminotyrosine suitably protected for the synthesis of a novel nonphosphorylated hexapeptide with low-nanomolar Grb2-SH2 domain-binding affinity
  2. Song, Y. L.; Roller, P. P.; Long, Y. Q.
  3. Bioorganic & Medicinal Chemistry Letters. 2004 14(12): 3205-3208.
  1. 22.   Enantioselective synthesis of (S)-3-carboxy-4-((carboxy)difluoromethyl)phenylalanine in protected form and its incorporation into a PTP-1B-directed tripeptide
  2. Kang, S. U.; Yang, G.; Li, W.; Zhang, Z. Y.; Burke, T. R.
  3. Chemistry & Biodiversity. 2004 1(4): 626-633.
  1. 23.   Synthesis of the first alpha-fluoro-phosphotyrosyl mimetic
  2. Shi, Z. D.; Liu, H. P.; Zhang, M. C.; Yang, D. J.; Burke, T. R.
  3. Synthetic Communications. 2004 34(21): 3883-3889.
  1. 24.   Design and initial characterization of a circular permuted variant of the potent HIV-inactivating protein cyanovirin-N
  2. Barrientos, L. G.; Louis, J. M.; Hung, J.; Smith, T. H.; O'Keefe, B. R.; Gardella, R. S.; Mori, T.; Boyd, M. R.; Gronenborn, A. M.
  3. Proteins-Structure Function and Genetics. 2002 46(2): 153-160.
  1. 25.   A QM/MM approach with effective fragment potentials applied to the dipeptide-water structures
  2. Nemukhin, A. V.; Grigorenko, B. L.; Bochenkova, A. V.; Topol, I. A.; Burt, S. K.
  3. Journal of Molecular Structure-theochem. 2002 581: 167-175.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel